142 related articles for article (PubMed ID: 16106426)
1. Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors.
Desrosiers RR; Rivard ME; Grundy PE; Annabi B
Pediatr Blood Cancer; 2006 Jan; 46(1):40-9. PubMed ID: 16106426
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
3. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
4. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
5. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
8. Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator.
Sid B; Dedieu S; Delorme N; Sartelet H; Rath GM; Bellon G; Martiny L
Int J Biochem Cell Biol; 2006; 38(10):1729-40. PubMed ID: 16807059
[TBL] [Abstract][Full Text] [Related]
9. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein receptor-related protein-1 (LRP-1) expression in a rat model of oxygen-induced retinal neovascularization.
Sánchez MC; Barcelona PF; Luna JD; Ortiz SG; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2006 Dec; 83(6):1378-85. PubMed ID: 16979164
[TBL] [Abstract][Full Text] [Related]
11. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
12. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors.
Chetcuti A; Aktas S; Mackie N; Ulger C; Toruner G; Alkan M; Catchpoole D
Pediatr Blood Cancer; 2011 Dec; 57(6):950-7. PubMed ID: 21387540
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte low-density lipoprotein receptor-related protein is post-transcriptionally regulated by extracellular matrix.
Schmoelzl S; Benn SJ; Laithwaite JE; Greenwood SJ; Marshall WS; Munday NA; FitzGerald DJ; LaMarre J
Lab Invest; 1998 Nov; 78(11):1405-13. PubMed ID: 9840615
[TBL] [Abstract][Full Text] [Related]
15. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of mesoblastic nephroma and Wilms tumors--comparison and clinical implications.
Sugimura J; Yang XJ; Tretiakova MS; Takahashi M; Kort EJ; Fulton B; Fujioka T; Vogelzang NJ; Teh BT
Urology; 2004 Aug; 64(2):362-8; discussion 368. PubMed ID: 15302496
[TBL] [Abstract][Full Text] [Related]
19. The expression of low density lipoprotein receptor-related protein in colorectal carcinoma.
Obermeyer K; Krueger S; Peters B; Falkenberg B; Roessner A; Röcken C
Oncol Rep; 2007 Feb; 17(2):361-7. PubMed ID: 17203175
[TBL] [Abstract][Full Text] [Related]
20. A gene expression signature for relapse of primary wilms tumors.
Li W; Kessler P; Yeger H; Alami J; Reeve AE; Heathcott R; Skeen J; Williams BR
Cancer Res; 2005 Apr; 65(7):2592-601. PubMed ID: 15805255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
